Palmitoylethanolamide

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 23:01, March 8, 2021 by Notjusttired (talk | contribs) (create)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Palmitoylethanolamide or PEA is a naturally occurring fatty acid that is available as a supplement.[1][2][3] PEA is also known as palmidrol.[3]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

Available over the counter.

Notable studies[edit | edit source]

  • 2012, New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoylethanolamide [1]
  • 2002, The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents?[2]
  • 2009, The potential benefits of palmitoylethanolamide in palliation: a qualitative systematic review[4] (Full text)
  • 2014, Palmitoylethanolamide in CNS health and disease[5] (Abstract)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]